NCT01056263View on ClinicalTrials.gov

Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Carcinoma, Renal Cell
Interventions
DRUG

axitinib: observational study

Non-interventional observational study

Trial Locations (8)

10065

Pfizer Investigational Site, New York

30625

Pfizer Investigational Site, Hanover

44195

Pfizer Investigational Site, Cleveland

53792

Pfizer Investigational Site, Madison

75651

Pfizer Investigational Site, Paris

94115

Pfizer Investigational Site, San Francisco

02114

Pfizer Investigational Site, Boston

02215

Pfizer Investigational Site, Boston

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY